Cargando…
A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
Over the last 15–20 years, remarkable developments of heart failure (HF) pharmacotherapies have been achieved. However, HF remains a global healthcare challenge with more than 64 million patients worldwide. Optimization of guideline‐directed chronic HF medical therapy is highly recommended with ever...
Autores principales: | Abdin, Amr, Bauersachs, Johann, Soltani, Samira, Eden, Matthias, Frey, Norbert, Böhm, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871719/ https://www.ncbi.nlm.nih.gov/pubmed/36229988 http://dx.doi.org/10.1002/ehf2.14197 |
Ejemplares similares
-
Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022) -
Timely and individualized heart failure management: need for implementation into the new guidelines
por: Abdin, Amr, et al.
Publicado: (2021) -
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
por: Schäfer, Andreas, et al.
Publicado: (2021) -
Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2022) -
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
por: Bak, Minjung, et al.
Publicado: (2023)